<!doctype html>
<html>
<head>
<meta charset="UTF-8">
<meta name="apple-mobile-web-app-capable" content="yes">
<meta name="viewport" content="width=device-width initial-scale=1, user-scalable=no">
<meta name="apple-mobile-web-app-title" content="Janssen | Remicade - REMICADE for paediatric IBD">
<title>Janssen | Remicade - REMICADE for paediatric IBD</title>
<link rel="stylesheet" type="text/css" href="css/animate.min.css" />
<link rel="stylesheet" type="text/css" href="css/style.css" />
<style type="text/css">
	.content .feature { width: 104.2%;  height:340px; margin:0 0 0 -40px; background-image:url('img/graph_6.png'); }
	.content .orange  { margin: 18px 0 1px; } 
	.orange > span { display:inline-block;  }
	.orange > span:first-child { width:43.5%; margin-right:10%; }
	.content .b { top:0; }
	
</style> 
</head>
<body>
	<section class="content-wrapper sides uc">
    	<header>
        	<span class="remicade-logo right"></span>
            <span class="section-label">Paediatric<br />UC</span> 
        	<div class="btn-menu">
                <ul class="popup-menu">
                    <li class="btn-home"><i></i></li>
                    <li class="btn-ref circle"></li>
                    <li class="btn-mpi circle"></li>
                    <li class="btn-info circle"></li>
                </ul>
            </div>
        </header>
    	<article class="inner-wrapper">
       		<div class="content">
                <h2 class="g-line">REMICADE may induce clinical remission and<br />
reduce steroid use<sup>1</sup></h2>
           
               <p>More than 38% of paediatric REMICADE responders treated 8-weekly achieved clinical remission<sup>†</sup></p>
                
               <p class="orange"><span>PUCAI Clinical Remission</span><span>Corticosteroid-free PUCAI Clinical Remission</span></p>
                <div class="feature"></div>
                
                <div class="footnote g-line">
                   Adapted from Hyams <em>et al</em>, 2012.<sup>1</sup> <sup class="b">†</sup>PUCAI clinical remission as defined by a score of &lt;10;<sup>1</sup> PUCAI, Paediatric Ulcerative Colitis Activity Index.
                   
              </div>
            
        	</div>
            
            <!--footer menu -->
            <ul class="footer-menu">
            	<li class="clinical active">Clinical<br />Remission</li>
                <li  class="steroid">Steroid<br />Sparing</li>
                <li class="mucosal">Mucosal<br />Healing</li>
                <li class="colectomy">Colectomy<br />Free Survival</li>
                <li class="acute">Acute<br />Severe</li>
            </ul>
       
        </article>
        <div class="popup ref">
            <h3>References</h3>
            <ol>
                <li class="ref1">Hyams J <em>et al</em>. Clin Gastroenterol Hepatol 2012; 10:391-99.</li>
            </ol>
        </div>
        <!--   Study design  -->
    	<div class="popup study-design">
    		<h3>Study design</h3>
      Hyams, 2012: Patients (6–17 years old) who had active ulcerative colitis (Mayo scores of 6–12;
endoscopic subscores ≥2) and had not responded to or tolerated conventional treatment were given 5
mg/kg REMICADE at weeks 0, 2, and 6. The primary end point was response at week 8 (decreases
in Mayo scores ≥30% and ≥3 points and decreases in rectal bleeding subscores of ≥1 or an absolute
subscore of ≤1). At week 8, only responders were randomly assigned to groups given REMICADE
q8w or q12w) and followed through week 54. Patients who lost response during the maintenance
phase were eligible to increase their REMICADE dose and/or frequency. Patients receiving
REMICADE 5 mg/kg q8w increased to 10 mg/kg q8w. Patients receiving REMICADE 5 mg/kg q12w
who lost response within 8 weeks of the previous REMICADE infusion had the dose and frequency
increased to 10 mg/kg REMICADE q8w, whereas patients in the same group who lost response
between 8 and 12 weeks after the previous infusion continued to receive 5 mg/kg REMICADE but
increased the frequency of infusions to q8w. Maintenance end points included PUCAI scores &lt;10
points, defined as remission.<sup>1</sup>
    	</div>
        
    <!-- popup main menu-->
        <aside class="main-menu animated">
        <span class="close circle"></span>
            <ul class="level1 paed">
                <li class="cd">
                    <ul class="play">
                        <li class="home" data-slide="home">
                            <span></span>
                            <span></span>
                            <span></span>
                        </li>
                        <li data-slide="cd">Crohn’s<br />disease</li>
                        <li data-slide="uc">Ulcerative<br />Colitis</li>
                    </ul>
                </li>
                <li class="common">
                    <ul class="play">
                        <li data-slide="st">Safety<br />& Tolerability</li>
                        <li data-slide="do">Dosing</li>
                        <li data-slide="ad">Adherence</li>
                        <li data-slide="pr">Preference</li>
                    </ul>
                </li>
            </ul>
        </aside>

    </section>
<script type="text/javascript" src="js/jquery-1.11.0.min.js"></script>
<script type="text/javascript" src="js/touchy.js"></script>
<script type="text/javascript" src="js/script.js"></script>
<script type="text/javascript">
	$( function(){
		//references
		goToSlide('ref1', 'Danese2011');
		goToSlide('ref2', 'Hoentjen2011');
		goToSlide('ref3', 'Lichtenstein2012');
		goToSlide('ref4', 'RemicadeData');
	})

</script>
</body>
</html>
